Anavex Life Sciences Corp (AVXL)

[polarbear77]

Curious, do you believe that the Company could be taking the below 5 actions over the last few months and through today IF they did NOT have current & sufficient SAB-reviewed supporting extension trial data with positive efficacy results showing continuing "dose dependent cognitive improvement" and "restores cellular homeostasis", and expect to avoid LEGAL ISSUES?

[Since the company is strangely not releasing anything new (as of now), just trying to solve the mystery myself.]

5 recent actions:
(1) starting an SEC regulated insider stock purchases plan for public visibility about 6 weeks ago (widely acknowledged as a likely display of internal confidence by the CEO), and
(2) continuing to make positive unambiguous efficacy assertions such as "provides dose dependent cognitive improvement" and "restores cellular homeostasis" in scientific and investor conference abstracts and p/r's to date, and
(3) continue to proclaim as recently as the August 2017 SEC quarterly filing that the 3 trials have been designed and are first of their kind in precision medicine (see quote below), and
(4) deciding to use the 12 month charts from Dec 2016 in June 2017 (positive charts) with older data than what they had in hand at that time in June 2017, and
(5) continue to sign up for upcoming scientific conferences such as today's 2017 Healthcare Conference and the 11/13 and 11/14 Neuroscience 2017 Conference